180 Life Sciences Corp. (NASDAQ: ATNF) is a clinical-stage biotechnology company focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University and Stanford University. 180 Life Sciences is leading the research into solving one of the world's biggest drivers of disease – inflammation.
Number of Employees:
10
.png){kind=logo}
.png){kind=logo}
Our Network
Unlock the gateway to wider business exposure with our exclusive 50% discount on all directory plans